PHILADELPHIA, Sept. 10, 2022 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of targeted cell therapies for ...

ClearLight Biotechnologies, Inc., today announced that it has added a customized MuVi SPIM CS Light-Sheet Microscope from Luxendo, a Bruker company, to its portfolio of imaging solutions. ClearLight ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio, a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer, genetic blood disorders and autoimmune diseases, ...

The drug is under Priority Review by the U.S. Food and Drug Administration (FDA) and has a Prescription Drug User Fee Act (PDUFA) date of June 23, 2025 NEW YORK, May 21, 2025--(BUSINESS ...

OXFORD, England--(BUSINESS WIRE)--Ochre Bio, a pioneer in chronic liver disease medicine development, has today announced the start of a multi-year data licence agreement with GSK. The partnership ...

- Data Presented at ASH; Company to Host Investor Call on December 10 - CAMBRIDGE, Mass. – December 8, 2014 – bluebird bio, Inc. (Nasdaq: BLUE) today announced data from eight subjects treated with ...

Intelligent Bio Solutions Inc. (NASDAQ:INBS) on Wednesday announced the collection of new data that further reinforces the security and performance of its Intelligent Fingerprinting Drug Screening ...